243 related articles for article (PubMed ID: 111451)
1. Drug-induced kinetic perturbations of the marrow blasts in acute leukemia. Effects of the daunorubicin, cytosine arabinoside and 6-thioguanine combination.
Amadori S; Petti MC; Mastrovincenzo C; Testa MG
Acta Haematol; 1979; 61(5):237-42. PubMed ID: 111451
[TBL] [Abstract][Full Text] [Related]
2. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
Presant CA; Berger NA; Klahr C; Phillips GL
Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
Malpas J; Mathé G; Hayat M
Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
[No Abstract] [Full Text] [Related]
4. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
[No Abstract] [Full Text] [Related]
5. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
[TBL] [Abstract][Full Text] [Related]
6. [Experiences in the treatment of acute myeloblastic leukemia and acute monocytic leukemia using cytosine arabinoside and 6-thioguanine].
Essers U; Althof S; Ewers M
Verh Dtsch Ges Inn Med; 1975; 81():1126-8. PubMed ID: 1065154
[No Abstract] [Full Text] [Related]
7. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.
Carey RW; Ribas-Mundo M; Ellison RR; Glidewell O; Lee ST; Cuttner J; Levy RN; Silver R; Blom J; Haurani F; Spurr CL; Harley JB; Kyle R; Moon JH; Eagan RT; Holland JH
Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of 17 cases of non-lymphoblastic acute leukemia with a combination of daunorubicin, cytosine and arabinoside].
Dini E; Barbui T; Cartei G; Chisesi T; Cazzavillan M; Battista R
Minerva Med; 1975 Jul; 66(52):2619-2620. PubMed ID: 1057055
[No Abstract] [Full Text] [Related]
9. [Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine].
Büchner T; Kamanabroo D; Hiddemann W; Urbanitz D
Verh Dtsch Ges Inn Med; 1978; (84):145-8. PubMed ID: 283634
[No Abstract] [Full Text] [Related]
10. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
[TBL] [Abstract][Full Text] [Related]
11. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine.
Evans DI; Jones PH; Morley CJ
Cancer; 1975 Nov; 36(5):1547-51. PubMed ID: 1059498
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute myeloid leukaemia with a triple cytotoxic regime: DAT.
Rees JK; Sandler RM; Challener J; Hayhoe FG
Br J Cancer; 1977 Dec; 36(6):770-6. PubMed ID: 271512
[TBL] [Abstract][Full Text] [Related]
14. Cell kinetics in leukemia. Correlation with clinical features and response to chemotherapy.
Vogler WR; Groth D; Garwood FA
Arch Intern Med; 1975 Jul; 135(7):950-4. PubMed ID: 1080405
[No Abstract] [Full Text] [Related]
15. [Results in the treatment of acute granulocytic leukemias using a combination of daunorubicine-cytosine arabinoside-cyclophosphamide. Apropos of 35 cases].
Bauters F; Plouvier B; Caulier MT; Mouton J; Goudemand M
Lille Med; 1974 Mar; 19(3):226-31. PubMed ID: 4612276
[No Abstract] [Full Text] [Related]
16. A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
Eur J Cancer (1965); 1974 Jul; 10(7):413-8. PubMed ID: 4532961
[No Abstract] [Full Text] [Related]
17. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
Burns CP
Cancer Chemother Rep; 1975; 59(4):757-60. PubMed ID: 1100227
[No Abstract] [Full Text] [Related]
18. Treatment of acute myeloid leukaemia with daunorubicin, cytosine arabinoside, mercaptopurine, L-asparaginase, prednisone and thioguanine: results of treatment with five multiple-drug schedules. Report of the Medical Research Council's Working Party on Leukaemia in Adults.
Br J Haematol; 1974 Jul; 27(3):373-89. PubMed ID: 4607313
[No Abstract] [Full Text] [Related]
19. Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocyte leukemia: a randomized collaborative study.
Mandelli F; De Lipsis E; Grignani F; Martelli M; Liso V; Amadori S
Med Pediatr Oncol; 1978; 4(3):231-40. PubMed ID: 277749
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.
Paolino W; Resegotti L; Rossi M; Infelise V
Br Med J; 1973 Sep; 3(5880):567-8. PubMed ID: 4516626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
